U.S. prescription drug prices see largest annual decline in 60 years

Prescription drug prices in the United States fell 3.1 percent over the twelve months ending in July, marking the steepest annual decline since March 1963. According to Bureau of Labor Statistics Consumer Price Index data, prices dropped 0.8 percent from June to July, continuing a trend where prices have fallen in five of the last six months.

Analysts attribute this decline to several factors, including increased generic and biosimilar competition for high-revenue brand-name drugs. Policy changes, such as reforms targeting Pharmacy Benefit Managers (PBMs) and the ability for consumers to bypass middlemen, are also cited as contributors to lower costs.

However, experts note that the Consumer Price Index measures a sampled basket of goods rather than individual pharmacy bills. Because patient costs are heavily influenced by insurance design, deductibles, and specific formulary tiers, a decline in the national index does not guarantee that every individual will see lower out-of-pocket expenses. Furthermore, while medicinal drugs saw a decline, other healthcare services like hospital and physician services continued to rise.